NOS3 and type 2 diabetes mellitus: If the bioavailability of NO as generated by the eNOS enzyme is decreased there may be an increased risk of the development of age-, environmental-, dietary-, and lifestyle-related diseases such as hypertension, atherosclerosis, insulin resistance or type 2 diabetes, and other CVD [64].